click below
click below
Normal Size Small Size show me how
ID 4
| Generic | Brand | Pharmacologic Category | Common Indications | Key Side Effects | Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| terbinafine (PO, topical) | Lamisil | Allylamine antifungal | Onychomycosis | nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache | --- | --- |
| fluconazole (PO, IV) | Diflucan | Azole antifungal | Vulvovaginal candidiasis, oropharyngeal candidiasis | nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | --- | --- |
| ketoconazole (PO, topical) | Nizoral | Azole antifungal | Fungal infections | nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | serious hepatotoxicity, sometimes requiring liver transplant, may cause QTc prolongation or drug interactions leading to QTc prolongation | --- |
| oseltamivir (PO) | Tamiflu | Neuraminidase inhibitor antiviral | Influenza | nausea, vomiting, neuropsychiatric events in pediatric patients | --- | --- |
| nystatin (PO) | --- | Polyene antifungal | Oropharyngeal candidiasis | No major side effects | --- | --- |
| nystatin (topical) | Nystop | Polyene antifungal | Cutaneous and mucocutaneous fungal infections | burning, itching | --- | only use oral solutions for thrush |
| micafungin (IV) | Mycamine | Echinocandin antifungal | Invasive candidiasis | No major side effects | --- | --- |
| betamethasone and clotrimazole (topical) | Lotrisone | Glucocorticoid and azole antifungal | Cutaneous fungal infections | burning, itching, dryness, skin atrophy | --- | do not use for diaper dermatitis; adrenal suppression with long-term use over large areas of skin |
| oseltamivir (PO) | Tamiflu | Neuraminidase inhibitor | Influenza | N/V, neuropsychiatric events in pediatrics | --- | --- |
| acyclovir (PO, IV) | Zovirax | Antiviral | HSV | N/, increased hepatic transaminases, crystalluria | --- | vessicant |
| valacyclovir (PO) | Valtrex | Antiviral | HSV | N/, increased hepatic transaminases | --- | --- |
| nirmatrelvir + ritonavir (PO) | Paxlovid | Antiviral | C19 | /D, dysgeusia | significant DDIs, strong 3A4 inhibitor | --- |
| remdesivir (IV) | Veklury | Antiviral | C19 | hyperglycemia, renal impairment | --- | --- |
| emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | NRTI | HIV infection, PreP, PEP | decreased bone density, kidney injury, N/V | post treatment of Hep. B; risk of resistance for preexposure prophylaxis | --- |
| emtricitabine + tenofovir alafenamide + bictegravir (PO) | Biktarvy | NRTI + INSTI | HIV infection | increased serum bilirubin, HA, weight gain, insomnia, N/D | post treatment of Hep. B | take INSTIs 2 hours before or 6 hours after products containing Ca/Al/Mg/Fe |